论文部分内容阅读
目的 :探讨改善心肺骤停脑复苏临床疗效的临床价值。方法 :选择我院在2014年3月~2016年4月期间收治的心肺骤停脑复苏病人51例,全部51例病人都采用综合药物疗法进行治疗,回顾分析其临床信息资料,探讨改善心肺骤停脑复苏临床疗效的有效方法,并观察其临床应用疗效。结果 :根据51例病人在我与治疗的相关信息中科看出,所以病人在进行综合药物疗法治疗后,取得了良好的治疗效果,其脑复苏率得到有效地提升,有效地保障了病人生命健康安全。结论 :在心肺骤停疾病的临床治疗中,采用综合药物疗法进行治疗,能够有效提升病人脑复苏率,改善病人身心健康状况,保障病人生命健康安全。
Objective: To explore the clinical value of improving the clinical efficacy of cardiopulmonary arrest and cerebral resuscitation. Methods: Fifty-one patients with brain-resuscitated cerebral resuscitation admitted from March 2014 to April 2016 in our hospital were enrolled in this study. All 51 patients were treated with comprehensive medical therapy. The clinical information and data were retrospectively analyzed, Stop the recovery of the clinical efficacy of effective methods, and observe the clinical application of curative effect. Results: Based on 51 cases of patients with information related to the treatment, we found that the patients achieved good therapeutic effects after comprehensive drug therapy and effectively improved the rate of brain recovery and effectively protected the lives of patients health and safety. Conclusion: In the clinical treatment of cardiopulmonary arrest diseases, the use of comprehensive drug therapy for treatment can effectively improve the rate of brain resuscitation, improve the physical and mental health of patients, and ensure the patient’s life and health and safety.